Artal Group S.A. - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 68 filers reported holding EVELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$6,070,000
-13.8%
1,000,0000.0%0.16%
+4.4%
Q3 2021$7,040,000
-48.8%
1,000,0000.0%0.16%
-43.4%
Q2 2021$13,740,000
+28.4%
1,000,0000.0%0.28%
+47.6%
Q1 2021$10,700,000
+26.4%
1,000,000
+42.9%
0.19%
+3.8%
Q4 2020$8,463,000
+238.1%
700,000
+47.4%
0.18%
+198.4%
Q3 2020$2,503,000
-23.4%
475,000
-28.7%
0.06%
-33.0%
Q2 2020$3,267,000666,6660.09%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders